Wells Fargo raised the firm’s price target on Centene (CNC) to $93 from $89 and keeps an Overweight rating on the shares. The firm notes Florida intends to award Medicaid contracts to Centene, Elevance Health (ELV), Humana (HUM) and two provider-run plans. Clearly the most positive for Centene given recent disappointing RFP performance and likely most disappointing for Molina Healthcare (MOH) given expectation for share gains, Wells says.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNC:
- Centene’s subsidiary Meridian selected by Michigan Department of Health
- Thursday Macro & Markets Update – 04.04.24
- Centene Announces James E. Murray’s Retirement for 2024
- Microsoft initiated, Broadcom upgraded: Wall Street’s top analyst calls
- Centene downgraded to Equal Weight from Overweight at Stephens
